Malaria, HIV and tuberculosis rage as perpetual epidemics in developing nations. Developed nations have an ethical duty and compelling socioeconomic reasons for combatting these global infectious diseases.
Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.